FDA issues new warning on misuse of UCB cough drug

03/12/2008 | Yahoo!

The FDA on Tuesday released a new warning on the potentially lethal side effects of misusing Tussionex Pennkinetic Extended-Release Suspension, a cough treatment manufactured by UCB S.A. The agency received reports of health problems and deaths in children and adults who took the drug, which contains hydrocodone, a narcotic pain reliever. "The FDA's alert is fully in line with our efforts to make sure this product is properly used," a UCB spokewoman said.

View Full Article in:

Yahoo!

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
CareFusion
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ
Project Manager RA - 15000003MD
Abbott
Santa Clara, CA
Director, Site Quality Management
CareFusion
Minneapolis, MN